Therefore, from this perspective, this study aimed to provide new insights into the pathophysiology of COVID-19-related systemic inflammatory response (SIR) while exploring PTX3-driven inflammatory response in the COVID-19 clinical setting. This evidence concerns the gene PTX3 and COVID-19.